| Literature DB >> 32294682 |
Aline Lopes Chagas1,2, Angelo Alves de Mattos3, Flair José Carrilho1,2, Paulo Lisboa Bittencourt4, Denise Cerqueira Paranaguá Vezozzo1, Natally Horvat1,5, Manoel de Souza Rocha1, Venâncio Avancini Ferreira Alves1,2, Gabriela Perdomo Coral3, Mario Reis Alvares-DA-Silva6, Fabio Marinho do Rego Barros7, Marcos Roberto Menezes1,2,5, Lucas Moretti Monsignore8, Fabricio Ferreira Coelho1, Renato Ferreira da Silva9, Rita de Cássia Martins Alves Silva9, Ilka de Fatima Santana Ferreira Boin10, Luiz Augusto Carneiro D Albuquerque1, José Huygens Parente Garcia11, Guilherme Eduardo Gonçalves Felga12, Airton Mota Moreira1,2, Maria Ignez Freitas Melro Braghiroli2, Paulo Marcelo Gehm Hoff2, Vivianne Barretto de Mello13, Mariana Fonseca Dottori14, Tiago Pugliese Branco2, Leonardo de Lucca Schiavon15, Thaisa de Fátima Almeida Costa2.
Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first recommendations about the management of HCC. Since then, new data have emerged in the literature, prompting the governing board of SBH to sponsor a single-topic meeting in August 2018 in São Paulo. All the invited experts were asked to make a systematic review of the literature reviewing the management of HCC in subjects with cirrhosis. After the meeting, all panelists gathered together for the discussion of the topics and the elaboration of updated recommendations. The text was subsequently submitted for suggestions and approval of all members of the Brazilian Society of Hepatology through its homepage. The present manuscript is the final version of the reviewed manuscript containing the recommendations of SBH.Entities:
Mesh：
Year: 2020 PMID： 32294682 DOI： 10.1590/S0004-2803.202000000-20
Source DB: PubMed Journal: Arq Gastroenterol ISSN： 0004-2803